License Agreement grants Sagimet a global, exclusive license to innovative forms of resmetirom active pharmaceutical ingredient (API) developed by TAPI and covered by TAPI patent applications ...

Alongside its consumer offerings, OSON continues to expand its Payments-as-a-Service (PaaS) platform for banks and fintech ...

Photo by Kamil Molendys on Unsplash The blockchain sector is no longer in the hype stage. By the end of 2025, companies assessing blockchain services will have a developed environment having actual ...

We are very much confident that we will be able to achieve our guidance of 20 percent plus growth in revenue, Managing ...

Petrobras approves the final investment decision for the SEAP II deepwater project, opening a new offshore production frontier in Brazil's Northeast.

While not an imminent priority, 2025 proved network APIs are no longer optional. As the ecosystem and partnerships continue ...

With Newsom’s blessing, Wicks negotiated a side deal where Google and California agreed to jointly contribute $125 million ...

India’s chip push is moving beyond fabs into the harder layer—chemicals, gases, and materials. These 3 Indian players are ...

Sagimet Biosciences Inc. stock rated Strong Buy on promising drug data and pipeline growth in acne and MASH. Click for this SGMT stock update.

Dong-A Socio Group is targeting the global market with a diversified strategy encompassing new drug development, raw pharmaceutical CDMO (contract development and manufacturing organization), ...

BMY has agreed to supply Eliquis free of charge to Medicaid starting in 2026 and will also donate seven tons of the active pharmaceutical ingredient used in Eliquis.